Kayexalate, K-Exit Poudre (CA), Kionex, PHL-Sodium Polystyrene Sulfonate (CA), PMS-Sodium Polystyrene Sulfonate (CA), Resonium A (UK), SPS Sodium Polystyrene Sulfonate Pharmacologic class:Cation exchange resin Therapeutic class:Potassium-removing resin ...
FDA于2015年10月22日曾发布药品安全通讯:要求对降血钾药聚苯乙烯磺酸钠(sodium polystyrene sulfonate),也称“降钾树脂”(商品名Kayexalate)开展药物相互作用研究。但最新FDA对这一规定进行了更新,并于2017年9月6日发布一则新的药品安全通讯:建议...
KAYEXALATE has the potential to bind other drugs. In in vitro binding studies, KAYEXALATE was shown to significantly bind the oral medications (n=6) that were tested. Decreased absorption oflithiumandthyroxinehave also been reported with co-administration of KAYEXALATE. Binding of KAYEXALATE to...
Kayexalate (and generic brandsKionexandSPS) is a potassium binder used to treat hyperkalemia. "The approved labeling for Kayexalate describes its potential to decrease absorption of lithium and thyroxine; however, extensive drug-drug interaction studies with Kayexalate have not been performed," the...
Kayexalate | 37349-16-9 英文名称:Kayexalate CAS No.:37349-16-9 分子式:UNSPECIFIED 分子量:183.20438 了解化合物详情 快速询单国内供应商 Kayexalate 数据 Mol: 37349-16-9.mol by:chem960.com ChemDraw08031019472D ……… 2.9297 4.7100 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.5700...
Provied information about Kayexalate(Molecular Formula: , CAS Registry Number:37349-16-9 ) ,Boiling Point,Melting Point,Flash Point,Density, Molecular Structure,Risk Codes,Synthesis Route at guidechem
必应词典为您提供kayexalate.的释义,网络释义: 聚苯乙烯磺酸钠;阳离子交换树脂;降钾树脂;
(100 mg) per gram of the drug. KAYEXALATE can be administered either orally or as an enema. ACTION Sodium polystyrene sulfonate is not absorbed from the gastrointestinal tract. As the resin passes through the gastrointestinal tract, the resin removes the potassium ions by exchanging it for ...
Sodium polystyrene sulfonate (kayexalate) aspiration: histologic appearance and infrared microspectrophotometric analysis of two cases Arch Pathol Lab Med (1996) J.A. Centeno et al. Fourier transform infrared microscopic identification of foreign materials in tissue sections Lab Invest (1992)Cited by ...
申请类型 NDA 申请号 011287 药品名称 KAYEXALATE 活性成分 SODIUM POLYSTYRENE SULFONATE 活性成分中文 暂无权限 执行时间 2009-05-13 持有公司 CONCORDIA 说明书 下载 VIP试用医疗器械查询APP下载客服中心常见问题数据可视化数据分析挖掘系统网站地图业务介绍友情链接 400-678-0778 投诉热线: (023) ...